Dopaminergic impairment and neuroinflammation in Parkinson's disease

被引:0
|
作者
Ouchi, Yasuomi [1 ]
机构
[1] Hamamatsu Univ Sch Med, Mol Imaging Res Ctr, Hamamatsu, Shizuoka 4313192, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:22P / 22P
页数:1
相关论文
共 50 条
  • [1] Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms
    Backman, Emmilotta A.
    Gardberg, Maria
    Luntamo, Laura
    Peurla, Markus
    Vahlberg, Tero
    Borghammer, Per
    Stefanova, Nadia
    Wenning, Gregor
    Kaasinen, Valtteri
    ANNALS OF NEUROLOGY, 2025,
  • [2] Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
    Kaur, Karamjeet
    Gill, Jaskamal Singh
    Bansal, Puneet Kumar
    Deshmukh, Rahul
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 308 - 314
  • [3] Dopaminergic impairment correlates with cortical dysfunction in Parkinson's disease.
    Ito, K
    Arahata, Y
    Nagano-Saito, A
    Abe, Y
    Kato, T
    Nakamura, A
    Kawasumi, L
    Hatano, K
    Yamada, T
    Kachi, T
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 225P - 225P
  • [4] Neuroinflammation in Parkinson’s Disease
    Jae-Kyung Lee
    Thi Tran
    Malú G. Tansey
    Journal of Neuroimmune Pharmacology, 2009, 4 : 419 - 429
  • [5] Neuroinflammation in Parkinson's Disease
    Lee, Jae-Kyung
    Tran, Thi
    Tansey, Malu G.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2009, 4 (04) : 419 - 429
  • [6] Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson's Disease Models
    Yang, Hanyu
    Wang, Lu
    Zang, Caixia
    Wang, Yue
    Shang, Junmei
    Zhang, Zihong
    Liu, Hui
    Bao, Xiuqi
    Wang, Xiaoliang
    Zhang, Dan
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [7] Early detection of dopaminergic dysfunction and glymphatic system impairment in Parkinson's disease
    Yao, Jun
    Huang, Ting
    Tian, Youyong
    Zhao, Hongdong
    Li, Rushuai
    Yin, Xindao
    Shang, Song'an
    Chen, Yu-Chen
    PARKINSONISM & RELATED DISORDERS, 2024, 127
  • [8] Dopaminergic impairment is related to cortical dysfunction in Parkinson's disease: A pet study
    Ito, K
    Arahata, Y
    Nagano-Saito, A
    Abe, Y
    Kato, T
    Nakamura, A
    Kawasumi, Y
    Hatano, K
    Yamada, T
    Kachi, T
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 449 - 453
  • [9] Cognitive Executive Impairment and Dopaminergic Deficits in De Novo Parkinson's Disease
    Siepel, Francoise J.
    Bronnick, Kolbjorn S.
    Booij, Jan
    Ravina, Bernard M.
    Lebedev, Alexander V.
    Pereira, Joana B.
    Gruner, Renate
    Aarsland, Dag
    MOVEMENT DISORDERS, 2014, 29 (14) : 1802 - 1808
  • [10] Identifying striatal and extrastriatal dopaminergic abnormalities of cognitive impairment in Parkinson's disease
    Christopher, L. M.
    Marras, C.
    Koshimori, Y.
    Lang, A. E.
    Houle, S.
    Strafella, A. P.
    MOVEMENT DISORDERS, 2012, 27 : S230 - S231